These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 35914728

  • 1. Biomarkers in Ocular Graft-Versus-Host Disease: Implications for the Involvement of B Cells.
    Shen Z, Ma J, Peng R, Hu B, Zhao Y, Liu S, Hong J.
    Transplant Cell Ther; 2022 Nov; 28(11):749.e1-749.e7. PubMed ID: 35914728
    [Abstract] [Full Text] [Related]

  • 2. Tear cytokine levels in the diagnosis and severity assessment of ocular chronic graft-versus-host disease(GVHD).
    Hu B, Qiu Y, Hong J.
    Ocul Surf; 2020 Apr; 18(2):298-304. PubMed ID: 31954196
    [Abstract] [Full Text] [Related]

  • 3. Ocular graft versus host disease in allogenic haematopoetic stem cell transplantation in a tertiary care centre in India.
    Khan R, Nair S, Seth T, Mishra P, Mahapatra M, Agarwal T, Tandon R, Vanathi M.
    Indian J Med Res; 2015 Nov; 142(5):543-8. PubMed ID: 26658588
    [Abstract] [Full Text] [Related]

  • 4. Tear Cytokines as Biomarkers for Acute Ocular Graft-Versus-Host Disease.
    Qiu Y, Hu B, Peng RM, Huang JF, Hong J.
    Cornea; 2022 Nov 01; 41(11):1405-1411. PubMed ID: 35184125
    [Abstract] [Full Text] [Related]

  • 5. Tear Lipid Metabolites As Potential Diagnostic Biomarkers for Ocular Chronic Graft-Versus-Host Disease.
    Ma J, Shen Z, Peng R, Li C, Hu B, Hong J.
    Transplant Cell Ther; 2021 Mar 01; 27(3):232.e1-232.e6. PubMed ID: 33781517
    [Abstract] [Full Text] [Related]

  • 6. The Role of IL-6, IL-10, and TNF-α in Ocular GVHD Following Allogeneic Transplantation.
    Chen Y, Zhuang X, Wang L, Xu Y, Sun Z, Ren Y, Chen F, Ma X, Tang X, Zhang X.
    Ocul Immunol Inflamm; 2024 Oct 01; 32(8):1788-1795. PubMed ID: 38252122
    [Abstract] [Full Text] [Related]

  • 7. Tear Cytokines Associated With Therapeutic Effects in Chronic Ocular Graft-Versus-Host Disease.
    Ma J, Shen Z, Peng R, Li C, Zhao Y, Hu B, Hong J.
    Cornea; 2023 Feb 01; 42(2):211-216. PubMed ID: 36582034
    [Abstract] [Full Text] [Related]

  • 8. Development and validation of a diagnostic model for the identification of chronic ocular graft-versus-host disease (oGVHD).
    Shen Z, Hu B, Tao L, Ma J, Peng R, Zhao Y, Hong J.
    Front Med (Lausanne); 2023 Feb 01; 10():1277194. PubMed ID: 37964878
    [Abstract] [Full Text] [Related]

  • 9. Tear Film Immunological Profile in Patients with Ocular Graft versus Host Disease.
    Serapicos P, Kim C, Barros SL, Mendes Silva Jordão IMB, Hiyane MI, Barbosa de Sousa L, Zecchin VG, Camara NOS, de Oliveira LA.
    Ocul Immunol Inflamm; 2023 May 01; 31(4):701-709. PubMed ID: 35404738
    [Abstract] [Full Text] [Related]

  • 10. Tear inflammatory mediators and protein in eyes of post allogenic hematopoeitic stem cell transplant patients.
    Nair S, Vanathi M, Mahapatra M, Seth T, Kaur J, Velpandian T, Ravi A, Titiyal JS, Tandon R.
    Ocul Surf; 2018 Jul 01; 16(3):352-367. PubMed ID: 29723628
    [Abstract] [Full Text] [Related]

  • 11. Ocular surface evaluation in allogenic hematopoietic stem cell transplantation patients.
    Vanathi M, Kashyap S, Khan R, Seth T, Mishra P, Mahapatra M, Tandon R.
    Eur J Ophthalmol; 2014 Jul 01; 24(5):655-66. PubMed ID: 24604604
    [Abstract] [Full Text] [Related]

  • 12. Effects and Safety of 5% Lifitegrast Ophthalmic Solution in Patients With Dry Eye Disease Associated With Ocular Graft-Versus-Host Disease.
    Wong CW, Le HL, Gombos DS, Yee RW.
    Cureus; 2024 Aug 01; 16(8):e66437. PubMed ID: 39246931
    [Abstract] [Full Text] [Related]

  • 13. Tear Cytokines as Biomarkers for Chronic Graft-versus-Host Disease.
    Jung JW, Han SJ, Song MK, Kim TI, Kim EK, Min YH, Cheong JW, Seo KY.
    Biol Blood Marrow Transplant; 2015 Dec 01; 21(12):2079-2085. PubMed ID: 26303101
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and retention of silicone punctal plugs for treatment of dry eye in patients with and without ocular graft-versus-host-disease.
    Singh RB, Yung A, Coco G, Sinha S, Dohlman TH, Yin J, Dana R.
    Ocul Surf; 2020 Oct 01; 18(4):731-735. PubMed ID: 32738300
    [Abstract] [Full Text] [Related]

  • 15. Ophthalmic manifestations are associated with reduced tear lymphotoxin-α levels in chronic ocular graft-versus-host disease.
    Ma J, Li C, Zhao Y, Shen Z, Hu B, Peng R, Hong J.
    BMC Ophthalmol; 2022 Jan 10; 22(1):18. PubMed ID: 35012541
    [Abstract] [Full Text] [Related]

  • 16. Molecular Biomarkers in Ocular Graft-versus-Host Disease: A Systematic Review.
    Bohlen J, Gomez C, Zhou J, Martinez Guasch F, Wandvik C, Sunshine SB.
    Biomolecules; 2024 Jan 12; 14(1):. PubMed ID: 38254702
    [Abstract] [Full Text] [Related]

  • 17. Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort study.
    Pietraszkiewicz AA, Payne D, Abraham M, Garced A, Devarasetty KC, Wall M, Menezes SM, Ugarte S, Pirsl F, Goklemez S, Ferris FL, Barrett J, Battiwalla M, Childs RW, Pavletic SZ, Bishop RJ.
    Bone Marrow Transplant; 2021 Aug 12; 56(8):1850-1858. PubMed ID: 33686249
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prevalence of neurotrophic keratopathy in patients with chronic ocular graft-versus-host disease.
    Singh RB, Yuksel E, Sinha S, Wang S, Taketani Y, Luznik Z, Yin J, Dohlman TH, Dana R.
    Ocul Surf; 2022 Oct 12; 26():13-18. PubMed ID: 35843560
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.